Drug General Information
Drug ID
D0J7OM
Former ID
DNC008099
Drug Name
6-(benzylamino)-9-butyl-9H-purine-2-carbonitrile
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529240]
Structure
Download
2D MOL

3D MOL

Formula
C17H18N6
Canonical SMILES
CCCCN1C=NC2=C1N=C(N=C2NCC3=CC=CC=C3)C#N
InChI
1S/C17H18N6/c1-2-3-9-23-12-20-15-16(21-14(10-18)22-17(15)23)19-11-13-7-5-4-6-8-13/h4-8,12H,2-3,9,11H2,1H3,(H,19,21,22)
InChIKey
OJVVVZACBFLFEJ-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Cathepsin L Target Info Inhibitor [529240]
KEGG Pathway Lysosome
Phagosome
Antigen processing and presentation
Proteoglycans in cancer
Rheumatoid arthritis
NetPath Pathway IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
Reactome Endosomal/Vacuolar pathway
Collagen degradation
Degradation of the extracellular matrix
Trafficking and processing of endosomal TLR
Assembly of collagen fibrils and other multimeric structures
MHC class II antigen presentation
WikiPathways Primary Focal Segmental Glomerulosclerosis FSGS
References
Ref 529240J Med Chem. 2008 Feb 14;51(3):545-52. Epub 2008 Jan 4.Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB.
Ref 529240J Med Chem. 2008 Feb 14;51(3):545-52. Epub 2008 Jan 4.Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB.

If you find any error in data or bug in web service, please kindly report it to Dr. Wang and Dr. Li.